اكتشف أفضل عيادات وتكاليف العلاج استئصال الرحم بالمنظار في الإمارات العربية المتحدة 2024

Dr. Hosam is a Consultant Obstetrician, Gynecologist, and Urologist. He worked for 20 years in the NHS in the United Kingdom after obtaining his CCST as a Consultant Gynecologist with known expertise in the management of high-risk pregnancy, complex benign gynecology, and early-stage gynecological cancer. He worked as a Consultant and the Lead Urogynecologist at Sussex Healthcare Trust, where he has been practicing since 2004. Dr. Hosam has a special interest in prolapse, urinary incontinence, sexual dysfunction (fertility preservation surgery), menorrhagia, and minimally invasive laparoscopic and hysteroscopic gynecological surgery (for abnormal bleeding, pelvic masses, and pelvic pain). He established an integrated multidisciplinary urogynecology team across the trust. He had led the obstetrics and gynecology department as a clinical director to attain national British Society of Urogynecology accreditation. He has extensive clinical and surgical expertise to manage urinary incontinence, frequency, urgency, and recurrent cystitis and to perform pelvic reconstructive surgery for incontinence and uterovaginal prolapse. A subjective retrospective audit of his continence surgery showed a success rate of 86% and a success rate of prolapsed surgery of 91%. He is also interested in the management of sexual dysfunction, including vaginal corrective surgery. Dr. Hosam was chosen to be a Member of the International Urogynecology Association’s Publication Committee, and he was also the Editor of the expert corner in the IUGA newsletter. His areas of expertise include, Minimally invasive laparoscopic and hysteroscopic surgery Menorrhagia, fibroid, and endometriosis Laparoscopic myomectomy and hysterectomy Urogynecology, pelvic floor surgery, and recurrent prolapse Female stress incontinence surgery High-risk pregnancy Prolapse and pelvic floor surgery Pelvic reconstruction surgery Stress incontinence treatment Urodynamics Urogynecology Endometriosis Fibroids Hysteroscopy Menopause and psychosexual problems Menorrhagia Laparoscopic hysterectomy and myomectomy Stress incontinence surgery (none mesh and minimally invasive procedures) Day case stress incontinence procedure without surgery Anal sphincter incontinence surgery Abdominal and vaginal suspension procedures Menstrual disorders Miscarriage Painful periods Pelvic/perineal pain Postpartum obstetric anal sphincter injuries Research & Publications Serum Cupper and Zinc in Unexplained Infertility Anti HLA Abs in Recurrent Miscarriage and Effect of Immune Therapy on Pregnancy Outcomes Unusual presentation of PRESS in the postnatal period. BMJ Case Reports 2014; doi:10.1136/bcr-2013-203406 Subphrenic abscess resulting in multi organ failure after Caesarean Section - case report. J. of obstet&Gynae.Vol 30; No.3,312-314,2010. Long Term outcome of the telephone follow up clinic in gynaecological setting. Int. J. of healthcare administration.vol 7, No.1.,2010. Role of 3D ultrasound in the diagnosis of rare case of angular pregnancy. The Internet Journal of Gynaecology and Obstetrics. 2009 Volume 11 Number 2. Unusual presentation of ectopic pregnancy. Therapeutic forum,MIMS Women's Health Vol 4,No 3,2009. Management of Ovarian Masses in Pregnancy. Trends in Gynaecology and Urology, Volume 14 Issue 1, p 14-17 (January/February 2009). Factors Affecting Success of Hysteroscopic Hydrothermablation Procedure: A One Year Data Assessment. Kent and Sussex Journal of Obstetrics and Gynaecology. Vol. 6, issue 2, Jan 2008. Value of the MRI in the Preoperative Assessment of the Endometrial Cancer. Int. J. of O&G, Vol. 8 No.2, December 2007. Perioperative Factors Affecting the Hysteroscopic Hydrothermablation Procedure: A Six-month Assessment. Obstetrics & Gynaecology, News J. March 2006. Evaluation of the Transvaginal Scan versus Hysteroscopy in Postmenopausal Bleeding. East Sussex Journal of O&G. March, 2006. Unusual Presentation of Cervical Ectopic Pregnancy. East Sussex Journal of O&G, March 2006. Reproductive Health of Women: A review of the Panoramic Heritage. The Alex Journal of History of Medicine. Vol 30 -33, issue 1, April 2005. The use of low molecular weight heparin in pregnant woman with Mitral valve heart disease. Kuwait Medical Journal, March 2002, vol.39, No.5, 53-54. Mean 3rd Trimester Blood Sugar in Diabetic Kuwaiti Pregnant Females as a Predictor for Fetal Macrosomia. Medscape Women’s Health, (United States), Oct 2001, 6(5) p2. Chronic Pelvic Pain in Women. Obstetric and Gynaecology Survey. November issue 2001. Autologus Fascial Sling ,Does it really help the stress incontinence ,One year outcome data. Outcome of the Bulkamid periurethral injection.Outcome of the Vaginal suspension procedure for the years 19/20/21 Perioperative factors that affect the outcome of the pelvic floor surgery IUGA 2019 MRI ,CT scan versus TVS in the diagnosis and management of adnexal mass over 3 years (Oral presentation at the international gynaecology and gynae-oncology in China) 2013 Perioperative factors affecting the success of the HTA, a 3 years follow up at the 13th international world controversies in Ob.Gyn. and infertility, Berlin, Germany. 4-7/11/2010 Is there is a place for uterine conservation in the management of early stage endometrial cancer. RCOG international conference Abu-Dhabi Dec. 6,7,8th 2009. Value of TVS in the initial assessment of high-risk postmenopausal women. Annual RCOG international conference Abu-Dhabi Dec. 2009-09-13 (Poster) Is there is a place for the local hysteroscopic resection for malignant polypoidal endometrial cancer? Annual Southeast Gynaecology Tumour Group meeting. 17 September 2007. (oral) Value of the MRI, Hysteroscopy and TVS in the Preoperative Staging of Endometrial Cancer. 31st British International Congress of Obstetrics and Gynaecology 4-6 July/2007. (oral) Hysteroscopic Hydrothermablation: A novel Ablative Technique. Grand round oral presentation in the East Sussex NHS Trust monthly meeting. Evaluation of Perioperative Factors Affecting Success of Hysteroscopic Hydrothermablation Procedure. Presented at the BSGE Annual Scientific meeting in Sheffield, May 2006. Evaluation of the Transvaginal Scan versus Hysteroscopy in Postmenopausal Women on Tamoxifen . Poster Presentation at the 19th EBCOG European Congress of Obstetrics and Gynaecology, April 2006, Torino, Italy. Induced Abortion Services in a District General Hospital. Poster presentation at the North Middlesex University Hospital Meeting, London, 26th May 2006. Outcome of the Hysteroscopy at Conquest Hospital over the last triennium 2004-2005. Part of the special skill module of the TVS in Gynaecology for the RCOG. Presented at the world 7th controversies in Obstetrics and Gynaecology in Athens, April 2005. Perinatal Mortality Audit at Jahra Hospital, Kuwait. Accepted by the CPD program of the RCOG 2001. Audit of the Outcome of the Burch Colposuspension over a 2-year period. Oral Presentation at the Annual Obstetrics and Gynaecology Conference, Kuwait Institute of Medical Specialisation, Kuwait 2003, Jahra Education & Training Master's Degree in Obstetrics and Gynaecology (Ain Shams University, Cairo, Egypt) FRCOG (Royal College of Obstetricians and Gynecologists) in the UK MD Doctorate Degree in Obstetrics and Gynecology (Ain Shams University, Cairo, Egypt) Royal College of Obstetrician and Gynecologist Subspecialty Modular training in Urogynaecology, minimally invasive laparoscopic and hysteroscopic surgery Membership British Society of Gynae-Endoscopy British Society of Urogynaecology

Dr. Alrawi is currently the Director of Oncology Services at VPS Hospital system in UAE & MENA having tertiary referral cancer centers for all UAE, with all supporting subspecialties including Surgical Oncology, Medical oncology and Radiation, in addition to palliative care and research. The system is an art of high qualified personals with western qualifications establishing the nucleus of quaternary referral center from MENA at Burjeel Medical City. Dr. Alrawi was the Director of Oncology Services (Surgery & Oncology) at Alzahra Hospital in the Heart of Dubai and its tertiary referral cancer center for all UAE, hosting highly specialized Surgical Oncology subspecialties, including Colorectal, Breast oncology, Head & Neck Surgery, Urology, Gynecological Oncology, Sarcoma/ Melanoma and Peritoneal surface malignancy, in addition to Pancreatic and Hepatic surgery. In his previous post, Dr. Alrawi was the Chief of Surgical Oncology Division at Tawam Hospital and the interim chair of department of surgery from October 2013-September 2015. Tawam Hospital is affiliated with JOHN HOPKINS Medical System. Dr. Alrawi has major interest is Gastrointestinal Oncology, including Esophageal, Gastric, Pancreas, Liver and Colonic Surgery with special interest in Endocrine Surgery including thyroid, parathyroid and adrenal.  Dr. Alrawi was trained in various Academic institutes in Surgical Oncology all over including Roswell Park, Cancer Institute, Buffalo, Royal Free Hospital, UC of London and Ninewells Hospital, U of Dundee. Dr. Alrawi, who is an American board certified, completed his Head & Neck fellowship and Surgical Oncology fellowship at Roswell Park Cancer institute (NCI) designated in 2006. Dr. Alrawi did advanced Laparoscopic oncology training with Professor Alfred Cuschieri in Dundee 1992-1993, advanced colorectal oncology training with E Lloyd Davis in Cornwall, England 1993-1995 and advanced surgical oncology with Professor Marc Winslett, London 1995-1996. He has received many academic and a scholarly honors while in training and during his clinical practice years, and is an often invited speaker at both public and professional meetings dedicate to helping education with cancer management.    Qualification MD FRCSEd FRCSEng CABS DGS American & British Boarded in Surgery & Surgical Oncology Fellowship Surgical Oncology Fellowship Head & Neck Surgery Roswell Park Cancer Institute, Buffalo, New York Director of Surgical Oncology Services at Al Zahra Hospital 2015 Chief of Surgical Oncology Division at Tawam Hospital 2013-2015. Chief of the Surgical Oncology Program at Comprehensive Cancer Center of 21st Century Oncology in Jacksonville, Florida from 2008- 2013. Head & Neck fellowship and Surgical Oncology fellowship at Roswell Park Cancer institute (NCI) designated in 2000-2006. Assistant professor in the Department of Surgery/Division of Surgical Oncology at University of Florida, Jacksonville. Fellow of Royal College of Surgeons of England FRCSEng 1994 Fellow of Royal College of Surgeons of Edinburgh FRCSEd 1992 Arab Board of Surgery 1992 Diploma General Surgery, Baghdad University 1991 Clinical Expertise & Services Surgical Oncology Upper GI Task Force Surgeon Head and Neck Oncology Minimal Invasive Oncology Breast Oncology Colorectal Oncology Heated Chemoperfusion Oncology research

Dr. Jafaru Abu is a Consultant Gynecological Oncology Surgeon who, prior to joining Burjeel Medical City, occupied a senior position at Nottingham University Hospitals, UK., and in a career span of nearly three decades, has put in nearly 20 years of extensive work in the OBGYN specialty, across a chain of leading hospitals in the UK.During this term of his service, from 2003 to 2006, Dr. Abu was Subspecialty Fellow in Gynecological Oncology/Senior Registrar in Obstetrics & Gynecology, University Hospitals of Leicester, United Kingdom. Earlier, he was Visiting Fellow in Gynecological Oncology, Royal Brisbane Hospital & Royal Women’s Hospital, Queensland, Australia and Royal Northshore Hospital Sydney, Australia. During the early part of Dr. Abu’s career, he had worked as Specialist Registrar and as Senior House Officer in OBGYN in the UK as well.As for Dr. Jafaru Abu’s educational background; he was a brilliant academic performer throughout his studies and qualified in the profession with excellent undergraduate and post-graduate medical qualifications. After gaining his first degree in Medicine, MBBS from the University of Benin Medical School, Nigeria, Dr. Abu moved to the United Kingdom where he undertook all of his postgraduate training and qualified as a member (and later a Fellow) of the Royal College of Obstetricians& Gynecologists, UK, (MRCOG, FRCOG) and also gained the BSCCP Accreditation from the British Society for Colposcopy and Cervical Pathology. Dr. Abu also studied and gained a master’s degree in clinical sciences from the University of Leicester, United Kingdom. During his Specialist training years, Dr. Abu obtained a double qualification, firstly, he was awarded the Certificate of Completion of Specialist Training in OBGYN from the Royal College of Obstetricians and Gynecologists, UK, and secondly, another Certificate of Completion of Sub-specialty Training in Gynecological Oncology awarded byThe Postgraduate Medical Education and Training Board (PMETB) and the Royal College of Obstetricians and Gynecologists, UK, to add to his portfolio of qualifications.Dr. Abu was also a Visiting Fellow to the Centre of for Gynecological Cancers and Minimally Invasive Surgery, Royal Brisbane Hospital & Royal Women’s Hospital, Queensland, Australia and The Royal Northshore Hospital Sydney, Australia in 2005. He was appointed as a Consultant Gynecological Oncology Surgeon at Nottingham University Hospitals in 2006, one of UK’s biggest Teaching Hospitals, where he led a major transformation in the surgical management of gynecological cancers by pioneering the introduction of several surgical procedures. He was instrumental in the introduction of minimally invasive procedures (keyhole operations) in the management of cancers of the womb, cervix (neck of the womb) and early stages of ovarian cancer. Dr. Abu is well renowned for his exceptional ability to perform complex key-hole procedures both laparoscopically and with the DaVinciRobot. He was one of the first gynecologists in the UK to perform Single Incision Laparoscopic Surgery (SILS), a “scarless” procedure.Dr. Abu is also well known for performing extensive surgery for advanced stages of ovarian cancer and led the Department of Gynecological Oncology at Nottingham University Hospital, UK, to become an Accredited Advanced Ovarian Cancer Cytoreductive Surgical Centre by The European Society of Gynecological Oncologists (ESGO). He was the Head of Gynecological Oncology at Nottingham University Hospitals, UK, until he joinedthe VPS Healthcare. Committed to the training of other consultants, he established the Annual Nottingham Advanced Laparoscopic Training Course for gynecology consultants across the United Kingdom in 2008 where he trained and mentored other consultant colleagues as well as Senior Trainees to acquire the skills needed for safe advanced laparoscopic surgery in women. The Masterclass course became very popular across Europe. He also teaches advanced laparoscopic surgical skills as a member of an international faculty of experts in IRCAD Minimally Invasive Surgical Training Centre in Strasbourg, France.